Acarbose

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
82
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

Diabetes Mellitus Type 2

Conditions

Diabetes Mellitus Type 2

Trial Timeline

Jan 1, 2004 โ†’ โ€”

About Acarbose

Acarbose is a approved stage product being developed by Bayer for Diabetes Mellitus Type 2. The current trial status is completed. This product is registered under clinical trial identifier NCT01244971. Target conditions include Diabetes Mellitus Type 2.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01244971ApprovedCompleted